Tags » GlaxoSmithKline

Investigational drug for psoriasis by Galapagos and GlaxoSmithKline


A phase 2a multi-center, randomized, double-blind, placebo-controlled, dose ranging study evaluated the efficacy of GSK2586184 in 66 patients with chronic plaque psoriasis. Compared to placebo, a significantly higher proportion of patients treated with the investigational drug met the primary endpoint of achieving 75% improvement from baseline in Psoriasis Area Severity Index score at week 12. 63 more words

Drugs / Natural Products / Devices

FDA Breakthrough Therapy Designation: Fifth Drug Receives FDA Approval

The FDA approves on April 17th, GlaxoSmithKline’s orphan drug Arzerra (Ofatumumab injection for intravenous infusion), the 5th drug to have the coveted Breakthrough Therapy Designation (BTD). 315 more words

FDA Breakthrough Therapy Designation

US FDA approves GSK's once-weekly type 2 diabetes drug, Tanzeum

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. 260 more words

Aurous Posts

Pharma company alleged for bribing doctors

UK drug company GlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors, BBC Panorama has discovered.

Eleven doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012. 191 more words

Health News

Karnataka drugs control dept to monitor Crocin Advance recall & Schedule H1 adherence

Karnataka drugs control department has already commenced a drive to monitor recall of entire stocks of Crocin Advance from all chemists and druggist outlets in the state. 257 more words

Aurous Posts